Pernix Therapeutics Holdings Inc (PTXTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,023 | 34,551 | 8,762 | 4,579 | 8,002 |
| Receivables | 36,647 | 20,601 | 14,758 | 4,133 | 11 |
| Inventories | 22,014 | 6,261 | 4,146 | 1,082 | N/A |
| Income taxes - deferred | 8,119 | 4,552 | 2,494 | 61 | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 517 |
| TOTAL | $95,715 | $68,110 | $32,090 | $11,481 | $8,563 |
| Non-Current Assets | |||||
| PPE Net | 6,947 | 912 | 1,214 | 140 | 1,048 |
| Investments And Advances | 5,711 | 4,452 | 1,503 | 0 | 0 |
| Intangibles | 141,215 | 8,877 | 10,962 | 1,409 | 0 |
| Other Non-Current Assets | 1,859 | 214 | 265 | 383 | 4,139 |
| TOTAL | $155,731 | $14,454 | $13,944 | $1,932 | $5,187 |
| Total Assets | $251,447 | $82,564 | $46,034 | $13,413 | $13,750 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,287 | 6,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 5,046 | 4,864 | 6,597 | 579 | 33 |
| Accrued Expenses | 38,485 | 20,617 | 12,656 | 7,457 | 60 |
| Other current liabilities | 8,131 | N/A | N/A | N/A | N/A |
| TOTAL | $53,947 | $31,480 | $19,254 | $8,036 | $4,790 |
| Non-Current Liabilities | |||||
| Long Term Debt | 41,350 | N/A | 5,000 | N/A | N/A |
| Other Non-Current Liabilities | 42,075 | 600 | 1,800 | 41 | 805 |
| TOTAL | $118,961 | $1,460 | $7,875 | $N/A | $805 |
| Total Liabilities | $172,908 | $32,940 | $27,129 | $8,036 | $5,595 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,772 | 2,603 | 2,269 | 366 | 366 |
| Common Shares | 289 | 258 | 226 | 209 | 73 |
| Retained earnings | 20,433 | 21,843 | 13,496 | 4,309 | -721 |
| Other shareholders' equity | 3,203 | 1,338 | 248 | 70 | 0 |
| TOTAL | $78,539 | $49,624 | $18,905 | $5,376 | $8,155 |
| Total Liabilities And Equity | $251,447 | $82,564 | $46,034 | $13,413 | $13,750 |